{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:21Z","timestamp":1792091361923,"version":"4.4.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arr.2025.102854","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:46:59Z","timestamp":1754430419000},"page":"102854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential"],"prefix":"10.1016","volume":"112","author":[{"given":"Pratyush","family":"Porel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Hunjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib1","first-page":"1","article-title":"Parkinson's disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib2","doi-asserted-by":"crossref","first-page":"16917","DOI":"10.3390\/ijms140816917","article-title":"ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer\u2019s disease","volume":"14","author":"Abdalla","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib3","article-title":"Inhibition of ACE retards tau hyperphosphorylation and signs of neuronal degeneration in aged rats subjected to chronic mild stress","volume":"2015","author":"AbdAlla","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2012.02.006","article-title":"Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures","volume":"46","author":"Abraham","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/HMBCI.2011.123","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by neuropeptides","volume":"7","author":"Aguilera","year":"2011","journal-title":"Horm. mol. biol. clin. investig."},{"key":"10.1016\/j.arr.2025.102854_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2017.12.007","article-title":"Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals\u2013a randomized double-blind pre-clinical study","volume":"346","author":"Ahmed","year":"2018","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.arr.2025.102854_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta (1-42) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14525","article-title":"Role of brain renin\u2013angiotensin system in depression: a new perspective","volume":"30","author":"Ali","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"14","key":"10.1016\/j.arr.2025.102854_bib9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/CS20160116","article-title":"Anxiolytic-and antidepressant-like effects of angiotensin-(1\u20137) in hypertensive transgenic (mRen2) 27 rats","volume":"130","author":"Almeida-Santos","year":"2016","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.arr.2025.102854_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18495","article-title":"The potential role of brain renin-angiotensin system in the neuropathology of parkinson's disease: friend, foe or turncoat?","volume":"28","author":"Al-Qahtani","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2025.102854_bib11","doi-asserted-by":"crossref","first-page":"102685","DOI":"10.1016\/j.arr.2025.102685","article-title":"Postbiotics as a therapeutic tool in Alzheimer's disease: Insights into molecular pathways and neuroprotective effects","volume":"106","author":"Aran","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1528-1167.2008.01581.x","article-title":"The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis","volume":"49","author":"Arga\u00f1araz","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.arr.2025.102854_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bja.2019.07.017","article-title":"Propranolol protects cerebral autoregulation and reduces hippocampal neuronal cell death through inhibition of interleukin-6 upregulation after traumatic brain injury in pigs","volume":"123","author":"Armstead","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jnc.14821","article-title":"Angiotensin II mediates the axonal trafficking of tyrosine hydroxylase and dopamine \u03b2-hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons","volume":"150","author":"Aschrafi","year":"2019","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2004.03.052","article-title":"The angiotensin I converting enzyme insertion\/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men","volume":"363","author":"Baghai","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2025.102854_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00228-016-2079-0","article-title":"Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial","volume":"72","author":"Bahramali","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2025.102854_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173706","article-title":"Signaling pathways and genetics of brain renin angiotensin system in psychiatric disorders: state of the art","author":"Barak","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2025.102854_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery","volume":"29","author":"Benicky","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","article-title":"Disruption of the ang II type 1 receptor promotes longevity in mice","volume":"119","author":"Benigni","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom12101429","article-title":"Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases","volume":"12","author":"Bild","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib21","article-title":"Renin angiotensin system in cognitive function and dementia","volume":"2013","author":"Bodiga","year":"2013","journal-title":"Asian J. Neurosci."},{"issue":"23","key":"10.1016\/j.arr.2025.102854_bib22","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1523\/JNEUROSCI.5901-11.2012","article-title":"Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-\u03b21\u201342 oligomers are revealed in vivo by using a novel animal model","volume":"32","author":"Brouillette","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.1996.tb15418.x","article-title":"Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo","volume":"118","author":"Brown","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1471-4159.1986.tb04539.x","article-title":"Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and huntington's disease caudate nucleus","volume":"47","author":"Butterworth","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102854_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00195-1","article-title":"Peripheral clearance of brain-derived A\u03b2 in alzheimer's disease: pathophysiology and therapeutic perspectives","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102854_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173063","article-title":"Targeting the renin angiotensin system for the treatment of anxiety and depression","volume":"199","author":"Chrissobolis","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021944","volume":"8","author":"Connick","year":"2018","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13480","article-title":"Activation of angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling","volume":"20","author":"Dang","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2025.102854_bib29","article-title":"Renin-angiotensin-system increases phosphorylated tau and reactive oxygen species in human cortical neuron cell line","volume":"32","author":"De Dios","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.arr.2025.102854_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fendo.2017.00108","article-title":"Angiotensins and Huntington\u2019s disease: a study on immortalized progenitor striatal cell lines","volume":"8","author":"De Mello","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1567205014666171016101816","article-title":"Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with alzheimer's disease dementia","volume":"15","author":"de Oliveira","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2011.11.005","article-title":"Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"65","author":"De Sarro","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2025.102854_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.03.011","article-title":"Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN","volume":"135","author":"Diniz","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/ph14020166","article-title":"Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer\u2019s mice","volume":"14","author":"Drews","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.HYP.22.4.496","article-title":"Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA","volume":"22","author":"Eggena","year":"1993","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep45780","article-title":"A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials","volume":"7","author":"Eleuteri","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102854_bib37","first-page":"197","article-title":"Advances in the renin angiotensin system: focus on angiotensin-converting enzyme 2 and angiotensin-(1\u20137)","volume":"59","author":"Ferrario","year":"2010"},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib38","first-page":"197","article-title":"Angiotensin II-inhibiting drugs have no effect on intraneuronal A\u03b2 or oligomeric A\u03b2 levels in a triple transgenic mouse model of alzheimer's disease","volume":"3","author":"Ferrington","year":"2011","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib39","first-page":"151","article-title":"Angiotensin II-inhibition: effect on Alzheimer\u2019s pathology in the aged triple transgenic mouse","volume":"4","author":"Ferrington","year":"2012","journal-title":"Am. J. Transl. Res."},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib40","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1167\/iovs.11-9167","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels","volume":"53","author":"Fujita","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrneurol.2016.84","article-title":"Genetic variants in alzheimer disease\u2014molecular and brain network approaches","volume":"12","author":"Gaiteri","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib42","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1172\/JCI87306","article-title":"Angiotensin receptors and \u03b2-catenin regulate brain endothelial integrity in malaria","volume":"126","author":"Gallego-Delgado","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"15","key":"10.1016\/j.arr.2025.102854_bib43","doi-asserted-by":"crossref","first-page":"24099","DOI":"10.18632\/oncotarget.15732","article-title":"Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson\u2019s disease","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2025.102854_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-38","article-title":"Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of parkinson's disease","volume":"9","author":"Garrido-Gil","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib45","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00429-016-1357-z","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells","volume":"222","author":"Garrido-Gil","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.arr.2025.102854_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fphar.2018.00440","article-title":"Targeting renin\u2013angiotensin system against Alzheimer\u2019s disease","volume":"9","author":"Gebre","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuint.2012.04.012","article-title":"The levels of renin\u2013angiotensin related components are modified in the hippocampus of rats submitted to the pilocarpine model of epilepsy","volume":"61","author":"Gouveia","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2025.102854_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111471","article-title":"Intranasal irbesartan reverts cognitive decline and activates the PI3K\/AKT pathway in an LPS-induced neuroinflammation mice model","volume":"128","author":"Gouveia","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1-2","key":"10.1016\/j.arr.2025.102854_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2005.03.038","article-title":"Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death","volume":"1045","author":"Grammatopoulos","year":"2005","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib50","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2007.09.043","article-title":"Angiotensin II protects against \u03b1-synuclein toxicity and reduces protein aggregation in vitro","volume":"363","author":"Grammatopoulos","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2025.102854_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-2-1","article-title":"Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra","volume":"2","author":"Grammatopoulos","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102854_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146353","article-title":"Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para-and trans-cellular pathways","volume":"1722","author":"Guo","year":"2019","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00424-017-1942-x","article-title":"Macrophages in neuroinflammation: role of the renin-angiotensin-system","volume":"469","author":"Hammer","year":"2017","journal-title":"Pfl\u00fcg. Arch.-Eur. J. Physiol."},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2460\/javma.20.12.0683","article-title":"Telmisartan as an add-on treatment for dogs with refractory idiopathic epilepsy: a nonrandomized, uncontrolled, open-label clinical trial","volume":"260","author":"Hanael","year":"2022","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.arr.2025.102854_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuro.2014.10.004","article-title":"Potential of protease inhibitor in 3-nitropropionic acid induced huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration","volume":"45","author":"Hariharan","year":"2014","journal-title":"Neurotoxicology"},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib56","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4103\/NRR.NRR-D-23-01403","article-title":"Decoding molecular mechanisms: brain aging and Alzheimer\u2019s disease","volume":"20","author":"Hayat","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/cap.2014.0003","article-title":"Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability","volume":"25","author":"Hellings","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.arr.2025.102854_bib58","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/01.STR.0000177867.39769.cb","article-title":"Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical White matter lesions in essential hypertension","volume":"36","author":"Henskens","year":"2005","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib59","first-page":"471","article-title":"Angiotensin biosynthesis and concentrations in the brain of normotensive and hypertensive rats","volume":"79","author":"Hermann","year":"1984","journal-title":"J. De. Physiol."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib60","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/01.jcp.0000186736.99523.1d","article-title":"Lisinopril May augment antidepressant response","volume":"25","author":"Hertzman","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.arr.2025.102854_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0255-9","article-title":"Memory is preserved in older adults taking AT1 receptor blockers","volume":"9","author":"Ho","year":"2017","journal-title":"Alzheimer's. Res. Ther."},{"issue":"51","key":"10.1016\/j.arr.2025.102854_bib62","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades alzheimer amyloid \u03b2-peptide (A\u03b2); retards A\u03b2 aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/jcbfm.2013.240","article-title":"PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice","volume":"34","author":"Huang","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acschemneuro.5b00329","article-title":"Sunitinib, a clinically used anticancer drug, is a potent AChE inhibitor and attenuates cognitive impairments in mice","volume":"7","author":"Huang","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nlm.2006.08.010","article-title":"Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats","volume":"87","author":"Jenkins","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2025.102854_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837890","article-title":"Protective effect of renin-angiotensin system inhibitors on Parkinson\u2019s disease: a nationwide cohort study","volume":"13","author":"Jo","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.arr.2025.102854_bib68","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1470320315583582","article-title":"Cerebroprotective effects of RAS inhibitors: beyond their cardio-renal actions","volume":"16","author":"Kalra","year":"2015","journal-title":"J. ReninAngiotensin Aldosterone Syst."},{"key":"10.1016\/j.arr.2025.102854_bib70","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in parkinson's disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"14","key":"10.1016\/j.arr.2025.102854_bib71","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.3390\/ijms23147686","article-title":"Renin-angiotensin system in Huntington\u2032 s disease: evidence from animal models and human patients","volume":"23","author":"Kangussu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102854_bib72","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.40725","article-title":"Renin-Angiotensin system: updated understanding and role in physiological and pathophysiological states","author":"Kanugula","year":"2023","journal-title":"Cureus 15. 6"},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/1352458507085760","article-title":"Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis","volume":"14","author":"Kawajiri","year":"2008","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102854_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimer's. Res. Ther."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib75","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3171\/JNS\/2008\/108\/3\/0458","article-title":"High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"108","author":"Keuskamp","year":"2008","journal-title":"J. Neurosurg."},{"issue":"15","key":"10.1016\/j.arr.2025.102854_bib76","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.3390\/ijms241512111","article-title":"Angiotensin regulation of vascular homeostasis: exploring the role of ROS and RAS blockers","volume":"24","author":"Koumallos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib77","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/ijms20030726","article-title":"Role of the angiotensin pathway and its target therapy in epilepsy management","volume":"20","author":"Krasniqi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib78","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0024-3205(02)01772-1","article-title":"Effects of losartan on the blood\u2013brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats","volume":"71","author":"Kucuk","year":"2002","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2004.05.007","article-title":"Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice","volume":"15","author":"Kurosaki","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41531-022-00340-9","article-title":"Angiotensin type-1 receptor and ACE2 autoantibodies in parkinson's disease","volume":"8","author":"Labandeira","year":"2022","journal-title":"npj Park. 's. Dis."},{"key":"10.1016\/j.arr.2025.102854_bib81","first-page":"67","article-title":"Brain renin-angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garcia","year":"2014","journal-title":"Front. neuroanat."},{"key":"10.1016\/j.arr.2025.102854_bib82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102854_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101919","article-title":"The intracellular renin-angiotensin system: friend or foe. Some light from the dopaminergic neurons","volume":"199","author":"Labandeira-Garcia","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib84","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","article-title":"The role of the brain renin-angiotensin system in parkinson's disease","volume":"13","author":"Labandeira-Garcia","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib85","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.29137","article-title":"Nigral neurons degenerating in parkinson's disease express the angiotensin receptor type 1 gene","volume":"37","author":"Labandeira-Garcia","year":"2022","journal-title":"Mov. Disord."},{"issue":"10216","key":"10.1016\/j.arr.2025.102854_bib86","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102854_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457459","article-title":"Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons","volume":"15","author":"Lage","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.arr.2025.102854_bib88","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.HYP.0000125143.73301.94","article-title":"Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model","volume":"43","author":"Lavoie","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib89","doi-asserted-by":"crossref","first-page":"R248","DOI":"10.1152\/ajpregu.00287.2009","article-title":"A map and new directions for the (pro) renin receptor in the brain: focus on A role of the (pro) renin receptor in neuronal cell differentiation","volume":"297","author":"Lazartigues","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.arr.2025.102854_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-9-49","article-title":"Increase of angiotensin II type 1 receptor auto-antibodies in Huntington\u2019s disease","volume":"9","author":"Lee","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102854_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly Male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"Bmj"},{"issue":"1-2","key":"10.1016\/j.arr.2025.102854_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(02)00081-3","article-title":"Association between genetic polymorphism of angiotensin-converting enzyme gene and parkinson's disease","volume":"199","author":"Lin","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib93","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2022.04.029","article-title":"Association of angiotensin receptor blockers with incident parkinson disease in patients with hypertension: a retrospective cohort study","volume":"135","author":"Lin","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.arr.2025.102854_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-6410-1-6","article-title":"Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17\u03b2-oestradiol-dependent and sex chromosome-independent","volume":"1","author":"Liu","year":"2010","journal-title":"Biol. Sex. Differ."},{"issue":"18","key":"10.1016\/j.arr.2025.102854_bib95","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.3390\/ijms221810139","article-title":"Brain renin\u2013angiotensin system as novel and potential therapeutic target for Alzheimer\u2019s disease","volume":"22","author":"Loera-Valencia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib96","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.20598","article-title":"Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of parkinsonism","volume":"81","author":"Lopez-Real","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2025.102854_bib97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/fcp.12421","article-title":"Effect of aliskiren, a direct renin inhibitor, on the protective action of antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice","volume":"33","author":"\u0141ukawski","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib99","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/0929866527666200110154523","article-title":"The renin-angiotensin system in Huntington\u2019s disease: villain or hero?","volume":"27","author":"Machado","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.arr.2025.102854_bib100","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00213-015-4189-2","article-title":"Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla","volume":"233","author":"Masaki","year":"2016","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib101","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1460-9568.2011.07840.x","article-title":"The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death","volume":"34","author":"Mertens","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2025.102854_bib102","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10787-020-00724-4","article-title":"Perindopril ameliorates experimental Alzheimer\u2019s disease progression: role of amyloid \u03b2 degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling","volume":"28","author":"Messiha","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib103","first-page":"73","article-title":"ACE variants and association with brain A\u03b2 levels in Alzheimer's disease","volume":"3","author":"Miners","year":"2010","journal-title":"Am. j. transl. res."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08935","article-title":"Captopril is more effective than perindopril against aluminium chloride induced amyloidogenesis and AD like pathology","volume":"8","author":"Mohapatra","year":"2022","journal-title":"Heliyon"},{"issue":"7806","key":"10.1016\/j.arr.2025.102854_bib105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib106","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/14656566.2019.1612365","article-title":"Evaluating ADS5102 (amantadine) for the treatment of Parkinson\u2019s disease patients with dyskinesia","volume":"20","author":"M\u00fcller","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.arr.2025.102854_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-019-1011-2","article-title":"The renin-angiotensin system in the central nervous system and its role in blood pressure regulation","volume":"22","author":"Nakagawa","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"issue":"12","key":"10.1016\/j.arr.2025.102854_bib108","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1172\/JCI7451","article-title":"Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway","volume":"104","author":"Nataraj","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2025.102854_bib109","first-page":"107","article-title":"Renal modulation: the renin-angiotensin-aldosterone system (RAAS)","author":"Natarajan","year":"2013","journal-title":"Nephrol. Fluid Electrolyte Physiol. Neonatol. Quest. Controv."},{"key":"10.1016\/j.arr.2025.102854_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-015-0119-0","article-title":"A phase ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimer's. Res. Ther."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib111","first-page":"266","article-title":"Interactions between oestrogen and the renin angiotensin system-potential mechanisms for gender differences in Alzheimer\u2019s disease","volume":"1","author":"O\u2019Hagan","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"5","key":"10.1016\/j.arr.2025.102854_bib112","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1152\/ajpregu.00096.2010","article-title":"Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult Male growth-restricted offspring","volume":"298","author":"Ojeda","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"28","key":"10.1016\/j.arr.2025.102854_bib113","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.2174\/0929867324666170407141955","article-title":"Role of tissue renin-angiotensin system and the chymase\/angiotensin-(1-12) axis in the pathogenesis of diabetic retinopathy","volume":"24","author":"Ola","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.arr.2025.102854_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-021-00778-8","article-title":"The use of angiotensin-converting enzyme inhibitors vs. Angiotensin receptor blockers and cognitive decline in Alzheimer\u2019s disease: the importance of blood-brain barrier penetration and APOE \u03b54 carrier status","volume":"13","author":"Ouk","year":"2021","journal-title":"Alzheimer's. Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib115","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.arr.2025.102854_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132587","article-title":"Design, synthesis and evaluation of piperazine clubbed 1, 2, 4-triazine derivatives as potent anticonvulsant agents","volume":"1257","author":"Pal","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.arr.2025.102854_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.102854_bib118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2022.12.009","article-title":"AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability","volume":"108","author":"Pedrosa","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2025.102854_bib119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pbb.2014.05.006","article-title":"Valsartan reverses depressive\/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice","volume":"124","author":"Ping","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1389557516666161025094539","article-title":"Angiotensin mediated oxidative stress and neuroprotective potential of antioxidants and AT1 receptor blockers","volume":"17","author":"Prusty","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/jrc.2020.19","article-title":"Men with adult-onset epilepsy: Their experiences of health care provider relationship qualities following neurosurgery","volume":"26","author":"Raffaele","year":"2020","journal-title":"Aust. J. Rehabil. Couns."},{"key":"10.1016\/j.arr.2025.102854_bib122","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2174\/0929867311320100008","article-title":"The renin-angiotensin system: new insight into old therapies.\"","author":"Ram\u00edrez-S\u00e1nchez","year":"2013","journal-title":"Curr. Med. Chem. 20. 10"},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib123","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/CS20201296","article-title":"Brain angiotensin system: a new promise in the management of epilepsy?","volume":"135","author":"Ramos","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.arr.2025.102854_bib124","series-title":"Angiotensin","first-page":"449","article-title":"Brain renin\u2013angiotensin system in the injured brain: the role of astrocytes and microglia","author":"Ramos","year":"2023"},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/ddi094","article-title":"A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor","volume":"14","author":"Ramser","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.arr.2025.102854_bib126","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0895-4356(99)00082-7","article-title":"Cardiovascular drug prescriptions and risk of depression in diabetic patients","volume":"52","author":"Rathmann","year":"1999","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2025.102854_bib127","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11062-019-09760-5","article-title":"Serum angiotensin-converting enzyme in patients suffering from multiple sclerosis and healthy controls: a pilot study","volume":"50","author":"Razazian","year":"2018","journal-title":"Neurophysiology"},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib128","doi-asserted-by":"crossref","first-page":"H766","DOI":"10.1152\/ajpheart.00632.2017","article-title":"Role of intracellular angiotensin II.\"","volume":"314","author":"Re","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib129","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41598-018-19577-7","article-title":"Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer\u2019s disease hallmarks","volume":"8","author":"Reinhardt","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/0929866527666191230103739","article-title":"Renin-angiotensin system and Alzheimer\u2019s disease pathophysiology: from the potential interactions to therapeutic perspectives","volume":"27","author":"Ribeiro","year":"2020","journal-title":"Protein Pept. Lett."},{"issue":"6522","key":"10.1016\/j.arr.2025.102854_bib131","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay0214","article-title":"Poverty, depression, and anxiety: causal evidence and mechanisms","volume":"370","author":"Ridley","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib132","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s13311-020-00986-4","article-title":"Novel interactions involving the mas receptor show potential of the Renin\u2013Angiotensin system in the regulation of microglia activation: altered expression in parkinsonism and dyskinesia","volume":"18","author":"Rivas-Santisteban","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib133","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1460-9568.2004.03621.x","article-title":"Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors","volume":"20","author":"Rodriguez-Pallares","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2025.102854_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-58","article-title":"Renin angiotensin system and gender differences in dopaminergic degeneration","volume":"6","author":"Rodriguez-Perez","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/glia.22765","article-title":"Interaction between NADPH-oxidase and r ho-kinase in angiotensin II-induced microglial activation","volume":"63","author":"Rodriguez-Perez","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.arr.2025.102854_bib136","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102854_bib137","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","article-title":"Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials","volume":"227","author":"Rosenblat","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2025.102854_bib138","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.29.1_supplement.968.19","article-title":"Angiotensin II reduces mRNA expression for glutamate transporters and glutamine synthetase in cultured hypothalamic astrocytes","volume":"29","author":"Ruginsk","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2025.102854_bib139","doi-asserted-by":"crossref","unstructured":"Rukavina Mikusic, Natalia Luc\u00eda, Ang\u00e9lica M. Pineda, and Mariela Mercedes Gironacci. Ang-(1-7) and Mas receptor in the brain. (2021).","DOI":"10.37349\/emed.2021.00046"},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0022-3859.188553","article-title":"Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of alzheimer's disease? An overview of research evidence in the elderly patient population","volume":"62","author":"Rygiel","year":"2016","journal-title":"J. Postgrad. Med."},{"issue":"6","key":"10.1016\/j.arr.2025.102854_bib141","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.npp.1300921","article-title":"A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding","volume":"31","author":"Saavedra","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2025.102854_bib142","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer\u2019s disease","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102854_bib143","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcvm.2016.00003","article-title":"Timeline of history of hypertension treatment","volume":"3","author":"Saklayen","year":"2016","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib144","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.21945","article-title":"A case of parkinsonism worsened by losartan: a probable new adverse effect","volume":"23","author":"Sarma","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2025.102854_bib145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2013.05.025","article-title":"Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of \u03b1-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL\/6J mice","volume":"73","author":"Sathiya","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.102854_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.601939","article-title":"The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions","volume":"14","author":"Sheng","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.arr.2025.102854_bib147","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3389\/fphar.2019.00932","article-title":"Neuropsychiatric disorders in chronic kidney disease","volume":"10","author":"Sim\u00f5es e Silva","year":"2019","journal-title":"Front. pharmacol."},{"issue":"35","key":"10.1016\/j.arr.2025.102854_bib148","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102854_bib149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11481-019-09894-7","article-title":"Activation of the protective arm of the renin angiotensin system in demyelinating disease","volume":"15","author":"Stone","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4884","key":"10.1016\/j.arr.2025.102854_bib150","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.3201232","article-title":"Astrocytes synthesize angiotensinogen in brain","volume":"242","author":"Stornetta","year":"1988","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib151","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2008.03.058","article-title":"Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-\u03b2 peptides","volume":"588","author":"Sun","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.arr.2025.102854_bib152","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004897","article-title":"Detrimental effects of centrally administered angiotensin II are enhanced in a mouse model of alzheimer disease independently of blood pressure","volume":"6","author":"Takane","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1-3","key":"10.1016\/j.arr.2025.102854_bib153","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-0115(02)00285-9","article-title":"The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception","volume":"111","author":"Tchekalarova","year":"2003","journal-title":"Regul. pept."},{"issue":"9","key":"10.1016\/j.arr.2025.102854_bib154","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.lfs.2004.10.012","article-title":"Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?","volume":"76","author":"Tchekalarova","year":"2005","journal-title":"Life Sci."},{"issue":"20","key":"10.1016\/j.arr.2025.102854_bib155","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.arr.2025.102854_bib156","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/acn3.52132","article-title":"Associations of renin\u2013angiotensin system inhibitor use with brain insulin signaling and neuropathology","volume":"11","author":"Tong","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib157","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.3390\/ijms25073845","article-title":"Huntington\u2019s disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib158","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cns.12802","article-title":"Candesartan ameliorates brain inflammation associated with alzheimer's disease","volume":"24","author":"Torika","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib159","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2011.07.047","article-title":"Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin-treated rats","volume":"226","author":"Tota","year":"2012","journal-title":"Behav. brain Res."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib160","article-title":"Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension","volume":"2012","author":"Tsuda","year":"2012","journal-title":"Int. J. Hypertens."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib161","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jamda.2018.08.002","article-title":"Exploiting drug-apolipoprotein e gene interactions in hypertension to preserve cognitive function: the 3-city cohort study","volume":"20","author":"Tully","year":"2019","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib162","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102854_bib163","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9293553","article-title":"Recent advances in the endogenous brain renin-angiotensin system and drugs acting on it","volume":"2021","author":"Urmila","year":"2021","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"11","key":"10.1016\/j.arr.2025.102854_bib164","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/NEN.0b013e3181fa0308","article-title":"Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death","volume":"69","author":"Valenzuela","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.327","article-title":"Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Cell death Dis."},{"key":"10.1016\/j.arr.2025.102854_bib166","series-title":"The Renin Angiotensin System in Cardiovascular Disease","first-page":"131","article-title":"Mitochondria: a key protagonist of the renin angiotensin system","author":"Varghese","year":"2023"},{"issue":"3","key":"10.1016\/j.arr.2025.102854_bib167","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"10","key":"10.1016\/j.arr.2025.102854_bib168","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1460-9568.2010.07448.x","article-title":"Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson\u2019s disease","volume":"32","author":"Villar-Cheda","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.arr.2025.102854_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.439","article-title":"The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system","volume":"8","author":"Villar-Cheda","year":"2017","journal-title":"Cell death Dis."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/pds.5176","article-title":"Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in parkinson's disease","volume":"30","author":"Visanji","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"12","key":"10.1016\/j.arr.2025.102854_bib171","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012044","article-title":"Can commonly prescribed drugs be repurposed for the prevention or treatment of alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK clinical practice research datalink","volume":"6","author":"Walker","year":"2016","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.arr.2025.102854_bib172","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain \u03b2-amyloid protein levels and improves spatial learning in a mouse model of alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.arr.2025.102854_bib173","first-page":"131","article-title":"Potential role of estrogen in the pathobiology and prevention of alzheimer's disease","volume":"1","author":"Wharton","year":"2009","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib174","article-title":"Peroxisome proliferator activated receptor-\u03b1 agonist slows the progression of hypertension, attenuates plasma interleukin-6 levels and renal inflammatory markers in angiotensin II infused mice","volume":"2012","author":"Wilson","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.arr.2025.102854_bib175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin\u2013angiotensin system: a diversity of functions and implications for CNS diseases","volume":"465","author":"Wright","year":"2013","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"issue":"22","key":"10.1016\/j.arr.2025.102854_bib176","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/hc4601.099404","article-title":"Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury","volume":"104","author":"Wu","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.arr.2025.102854_bib177","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.arr.2025.102854_bib178","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7555\/JBR.30.20150131","article-title":"Autoantibodies in Alzheimer\u2019s disease: potential biomarkers, pathogenic roles, and therapeutic implications","volume":"30","author":"Wu","year":"2016","journal-title":"J. Biomed. Res."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib179","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCRESAHA.113.300752","article-title":"Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond","volume":"113","author":"Xia","year":"2013","journal-title":"Circ. Res."},{"issue":"7907","key":"10.1016\/j.arr.2025.102854_bib180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41586-022-04590-8","article-title":"Tethered peptide activation mechanism of the adhesion GPCRs ADGRG2 and ADGRG4","volume":"604","author":"Xiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102854_bib181","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2011.09.016","article-title":"Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats","volume":"1421","author":"Yamada","year":"2011","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.arr.2025.102854_bib182","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/cpt.1374","article-title":"Progress of pharmacological approaches in parkinson's disease","volume":"105","author":"Zeuner","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.arr.2025.102854_bib183","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cns.12015","article-title":"The neuroprotective effect of losartan through inhibiting AT 1\/ASK 1\/MKK 4\/JNK 3 pathway following cerebral I\/R in rat hippocampal CA 1 region","volume":"18","author":"Zhang","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib184","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1681\/ASN.2014010085","article-title":"Multiple genes of the renin-angiotensin system are novel targets of Wnt\/\u03b2-catenin signaling","volume":"26","author":"Zhou","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.arr.2025.102854_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes \u03b2 amyloid production in sprague dawley rats","volume":"6","author":"Zhu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2025.102854_bib186","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2016.02.026","article-title":"Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis","volume":"363","author":"\u017divkovi\u0107","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"46","key":"10.1016\/j.arr.2025.102854_bib187","doi-asserted-by":"crossref","first-page":"31914","DOI":"10.1074\/jbc.M109.011437","article-title":"A\u03b242-to-A\u03b240-and angiotensin-converting activities in different domains of angiotensin-converting enzyme","volume":"284","author":"Zou","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:45:32Z","timestamp":1780127132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":187,"alternative-id":["S1568163725002004"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102854","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102854"}}